ArticleCase reports in oncology
Natural History of Phosphoglyceride Crystal Deposition Disease of the Rib on Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography: A Case Report.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Phosphoglyceride crystal deposition disease (PCDD) is characterized by the deposition of phosphoglyceride crystals in the soft tissue or bone, forming tumor-like structures. Case Presentation: Herein, we report a case of slow-growing PCDD of the rib followed for 11 years in a 84-year-old man who had received the surgery for lung cancer. The diagnosis was based on computed tomography (CT)-guided needle biopsy. Initial fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) conducted in 2015 showed no apparent abnormal findings in the left third rib bone. FDG-PET/CT in 2018 revealed an expansive, lytic lesion measuring 9 mm in long size in the left third rib posterior arc with weak FDG uptake (maximum standardized uptake value [SUVmax] of 2.72). In the past 8 years, the mass increased to 24 mm with increasing of FDG uptake (SUVmax of 13.35), and did not show any findings such as cortical breakthrough, peritoneal reaction, soft tissue component, or pathological fracture. Conclusion: We should keep this rare disease which shows slow-growing in mind.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.